Blue Goat Cyber Leadership
Meet the Team Guiding You to FDA Cybersecurity Success
Navigating the FDA’s evolving cybersecurity requirements is high-stakes, high-stress, and highly technical—especially for medical device manufacturers preparing 510(k), PMA, or De Novo submissions. With complex documentation, rigorous risk management expectations, and pressure to secure patient safety, there’s no room for error. A single misstep can delay approval, increase costs, or jeopardize market access.
At Blue Goat Cyber, our leadership team combines deep FDA regulatory knowledge, hands-on penetration testing experience, and proven expertise in medical device cybersecurity to guide you through every step of your premarket submission. We understand the language of both engineers and regulators, ensuring your cybersecurity plans, SBOMs, threat models, and risk assessments meet FDA expectations the first time.
With over a decade of experience and a 100% success rate across FDA cybersecurity submissions—including 510(k) and PMA pathways—we help MedTech innovators reduce risk, protect patients, and get to market faster. Whether you’re building your first submission or correcting past deficiencies, you can trust our team to deliver results that are accurate, efficient, and fully aligned with FDA guidance.
Let our experts help you transform complex cybersecurity requirements into FDA-ready documentation—and take the stress out of compliance.
Christian Espinosa
Founder and CEO
Rick Turner
VP, MedTech Cybersecurity Solutions
Trevor Slattery
CTO and Director of MedTech Cybersecurity
Melissa Espinosa
VP, Strategic Partnerships
